pirtobrutinib

Italy

Drugs containing this active substance

  • JAYPIRCA

    It is an anticancer drug used to treat mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) in adult patients who have already received other BTK inhibitor treatments and for whom the tumor has recurred or has not responded to treatment.

    Form: tablets, film-coated

    Active substance Dosage
    pirtobrutinib -

    ATC: L01EL05

    Manufacturer: ELI LILLY NEDERLAND B.V.